Table 1.
Factor | Rad51 negative | Rad51 positive | P value |
---|---|---|---|
(n = 36) | (n = 53) | ||
Age (year) | 62.3 ± 10.1 | 64.1 ± 9.9 | 0.5193 |
Sex | 0.5144 | ||
Male | 33 (91.7 %) | 45 (84.9 %) | |
Female | 3 (8.3 %) | 8 (15.1 %) | |
Differentiation of ESCC | 0.0999 | ||
Well | 8 (22.2 %) | 15 (28.3 %) | |
Moderate | 24 (66.7 %) | 24 (45.3 %) | |
Poor | 4 (11.1 %) | 14 (26.4 %) | |
Location | 0.1083 | ||
Upper | 3 (8.4 %) | 8 (15.1 %) | |
Middle | 21 (58.3 %) | 19 (35.9 %) | |
Lower | 12 (33.3 %) | 26 (49.1 %) | |
Depth of invasion | 0.1246 | ||
pT 1, 2 | 25 (69.4 %) | 27 (50.9 %) | |
pT 3 | 11 (30.6 %) | 26 (49.1 %) | |
Lymph node metastasis | 0.0168 | ||
pN 0 | 25 (69.4 %) | 22 (41.5 %) | |
pN 1 | 11 (30.6 %) | 31 (58.5 %) | |
Lymphatic involvement | 0.2794 | ||
Negative | 22 (61.1 %) | 25 (47.2 %) | |
Positive | 14 (38.9 %) | 28 (52.8 %) | |
Vascular involvement | 1.0000 | ||
Negative | 25 (69.4 %) | 36 (67.9 %) | |
Positive | 11 (30.6 %) | 17 (32.1 %) | |
pStage | 0.0905 | ||
I, II | 30 (83.3 %) | 35 (66.0 %) | |
III | 6 (16.7 %) | 18 (34.0 %) | |
Recurrence | 0.0171 | ||
Negative | 27 (75.0 %) | 26 (49.1 %) | |
Positive | 9 (25.0 %) | 27 (50.9 %) |
ESCC esophageal squamous cell carcinoma